Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Apr 1;5(7):1903–1914. doi: 10.1182/bloodadvances.2020003865

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by The American Society of Hematology

This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 2. — Cumulative incidence of progression to HCoV LRTI by day 90 among 279 patients presenting with first HCoV URTI. P value is < .01 with Gray’s tests. Among 129 patients with no steroid, none of 13 patients with glucose values >150 mg/dL progressed to LRTI and 7 of 116 (6%) patients with glucose values ≤150 mg/dL or unknown progressed to LRTI. With the limited sample size, we combined those as a group of no steroid use.